AgeX Therapeutics, Inc. (AMEX:AGE) went up by 6.18% from its latest closing price when compared to the 1-year high value of $3.91 and move down -291%, while AGE stocks collected +17.65% of gains with the last five trading sessions. Press Release reported on 06/16/20 that AgeX Therapeutics and Pluristyx Announce Manufacturing, Marketing, and Distribution Agreement to Expand Access to Clinical-Grade Human Pluripotent Stem Cells for Therapeutic Applications
AGE Market Performance
AGE stocks went up by 17.65% for the week, with the monthly jump of 32.45% and a quarterly performance of 23.46%, while its annual performance rate touched -72.68%. The simple moving average for the period of the last 20 days is 11.55% for AGE stocks with the simple moving average of -24.30% for the last 200 days.
AGE Stocks 20.72% Far from 50 Day Moving Average
After a stumble in the market that brought AGE to its low price for the period of the last 52 weeks, AgeX Therapeutics, Inc. was unable to take a rebound, for now settling with -74.43% of loss for the given period.
The stock volatility was left at 19.26%, however, within the period of a single month, the volatility rate increased by 12.28%, while the shares sank at the distance of -11.50% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +25.00% upper at the present time.
In the course of the last 5 trading sessions, AGE went up by +17.65%, which changed the moving average for the period of 200 days to the total of -63.90% of losses for the stock in comparison to the 20-day moving average settled at $0.8900. In addition, AgeX Therapeutics, Inc. saw -45.05% in overturn over the period of a single year with a tendency to cut further losses.
AGE Stock Fundamentals
The current profitability levels are settled at -726.79 for the present operating margin and +42.22 for gross margin. The net margin for AgeX Therapeutics, Inc. stands at -703.36. Total capital return value is set at -196.17, while invested capital returns managed to touch -217.17. Equity return holds the value -388.60%, with -157.70% for asset returns.
Based on AgeX Therapeutics, Inc. (AGE), the company’s capital structure generated 88.19 points for debt to equity in total, while total debt to capital is set at the value of 46.86.
The value for Enterprise to Sales is 15.13 with debt to enterprise value settled at 0.03. The receivables turnover for AgeX Therapeutics, Inc. is 7.00 with the total asset turnover at the value of 0.19. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.23.